Covidien

Mallinckrodt to acquire CNS Therapeutics

Tuesday, September 25, 2012 10:31 AM

Mallinckrodt, the pharmaceuticals business of Covidien, a global healthcare products company, has agreed to acquire CNS Therapeutics, a St. Paul, Minn.-based specialty pharmaceutical company focused on neurological disorders and intractable chronic pain.

More... »

Covidien opens $45M R&D facility in China

Thursday, August 2, 2012 02:30 PM

Covidien, a global provider of healthcare products, has officially opened its China Technology Center (CTC) Research and Development (R&D) facility in Shanghai.

More... »

Covidien to acquire Oridion Systems

Friday, April 6, 2012 11:22 AM

Covidien, a global healthcare products company, will be acquiring Jerusalem-based Oridion Systems, creator of Microstream etCO₂ monitoring and sampling technologies.

More... »

Covidien to launch spin-off pharmaceuticals business

Thursday, December 15, 2011 02:27 PM

Covidien, a global provider of healthcare products, plans to spin off its pharmaceuticals business into a standalone public company.

More... »

Coviden to acquire BARRX Medical for $325 million

Monday, November 21, 2011 09:17 AM

BARRX Medical, a developer of minimally invasive medical devices, has signed a definitive agreement to be acquired by Covidien. Covidien is a global provider of healthcare products and a worldwide leader in advanced energy-based devices.

More... »

Tengion names Flora to board of directors

Wednesday, September 28, 2011 11:45 AM

Tengion has named Scott Flora to its board of directors. Flora brings to Tengion more than 20 years of experience building and managing successful wound healing and surgical device businesses.  He most recently served as global business unit president of surgical devices at Covidien.

More... »

Covidien could be selling pharma unit

Wednesday, June 8, 2011 02:51 PM

Covidien is looking to sell its pharmaceuticals unit for as much as $4 billion, according to a source familiar with the situation, Reuters has reported.

More... »

Pearl Therapeutics appoints new president and CEO

Friday, March 11, 2011 11:33 AM

Pearl Therapeutics has named Chuck Bramlage president and chief executive officer. In addition, Mr. Bramlage will join the company's board of directors.

More... »